- Home
- ROIV vs BROS Comparison
ROIV vs BROS Comparison
Compare ROIV & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BROS
- Stock Information
- Founded
- ROIV 2014
- BROS 1992
- Country
- ROIV United Kingdom
- BROS United States
- Employees
- ROIV N/A
- BROS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BROS Restaurants
- Sector
- ROIV Health Care
- BROS Consumer Discretionary
- Exchange
- ROIV Nasdaq
- BROS Nasdaq
- Market Cap
- ROIV 8.4B
- BROS 7.6B
- IPO Year
- ROIV N/A
- BROS 2021
- Fundamental
- Price
- ROIV $10.79
- BROS $73.73
- Analyst Decision
- ROIV Buy
- BROS Strong Buy
- Analyst Count
- ROIV 4
- BROS 15
- Target Price
- ROIV $17.50
- BROS $78.27
- AVG Volume (30 Days)
- ROIV 5.9M
- BROS 2.9M
- Earning Date
- ROIV 05-29-2025
- BROS 05-07-2025
- Dividend Yield
- ROIV N/A
- BROS N/A
- EPS Growth
- ROIV N/A
- BROS 109.32
- EPS
- ROIV N/A
- BROS 0.38
- Revenue
- ROIV $122,585,000.00
- BROS $1,361,068,000.00
- Revenue This Year
- ROIV N/A
- BROS $26.31
- Revenue Next Year
- ROIV N/A
- BROS $23.86
- P/E Ratio
- ROIV N/A
- BROS $191.83
- Revenue Growth
- ROIV 140.04
- BROS 30.42
- 52 Week Low
- ROIV $8.73
- BROS $26.96
- 52 Week High
- ROIV $13.06
- BROS $86.88
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- BROS 70.63
- Support Level
- ROIV $10.58
- BROS $58.20
- Resistance Level
- ROIV $11.77
- BROS $65.14
- Average True Range (ATR)
- ROIV 0.34
- BROS 2.59
- MACD
- ROIV -0.07
- BROS 1.53
- Stochastic Oscillator
- ROIV 17.65
- BROS 98.83
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.